{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:59:22Z","timestamp":1791482362578,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007206","name":"VICTR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.urology.2022.08.053","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T23:09:42Z","timestamp":1665788982000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The Financial Burden of Nephrolithiasis and Predictors of Disease-specific Financial Toxicity"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2862-0506","authenticated-orcid":false,"given":"Jackson","family":"Cabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Gelikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.08.053_bib0001","first-page":"490","article-title":"Kidney stones: treatment and prevention","volume":"99","author":"Fontenelle","year":"2019","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.urology.2022.08.053_bib0002","doi-asserted-by":"crossref","first-page":"e55491","DOI":"10.1371\/journal.pone.0055491","article-title":"\u201cHow much will I get charged for this?\u201d Patient charges for top ten diagnoses in the emergency department","volume":"8","author":"Caldwell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2022.08.053_bib0003","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.ju.0000152082.14384.d7","article-title":"Urologic diseases in America project: urolithiasis","volume":"173","author":"Pearle","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005392-199907000-00007","article-title":"A prospective study of recurrence rate and risk factors for recurrence after a first renal stone","volume":"162","author":"Trinchieri","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.urology.2015.07.006","article-title":"Urinary stone disease: progress, status, and needs","volume":"86","author":"Kirkali","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.08.053_bib0006","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.urology.2011.10.007","article-title":"Association of depression and urolithiasis","volume":"79","author":"Angell","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.08.053_bib0007","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.juro.2012.04.015","article-title":"Health related quality of life for stone formers","volume":"188","author":"Bryant","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0008","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.juro.2008.01.116","article-title":"Determinants of quality of life for patients with kidney stones","volume":"179","author":"Bensalah","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0009","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.juro.2007.08.009","article-title":"Health related quality of life differs between male and female stone formers","volume":"178","author":"Penniston","year":"2007","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urology.2022.08.053_bib0010","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.juro.2012.08.247","article-title":"Development of an instrument to assess the health related quality of life of kidney stone formers","volume":"189","author":"Penniston","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0011","doi-asserted-by":"crossref","first-page":"c91","DOI":"10.1159\/000102995","article-title":"Quality of life of patients with nephrolithiasis and recurrent painful renal colic","volume":"106","author":"Diniz","year":"2007","journal-title":"Nephron - Clin Pract"},{"key":"10.1016\/j.urology.2022.08.053_bib0012","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1523-1755.2005.00599.x","article-title":"Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?","volume":"68","author":"Saigal","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.urology.2022.08.053_bib0013","first-page":"278","article-title":"Economic impact of urinary stones","volume":"3","author":"Hyams","year":"2014","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0014","first-page":"465","article-title":"Economic impact of urologic disease","author":"Litwin","year":"2012","journal-title":"Urol Dis Am"},{"issue":"1","key":"10.1016\/j.urology.2022.08.053_bib0015","first-page":"349","article-title":"Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors","volume":"29","author":"Ver Hoeve","year":"2021","journal-title":"Support Care Cancer"},{"issue":"20","key":"10.1016\/j.urology.2022.08.053_bib0016","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"De Souza","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.urology.2022.08.053_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","article-title":"A systematic review of financial toxicity among cancer survivors: we can't pay the co-pay","volume":"10","author":"Gordon","year":"2017","journal-title":"Patient"},{"issue":"3","key":"10.1016\/j.urology.2022.08.053_bib0018","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.urology.2022.08.053_bib0019","first-page":"83","article-title":"Financial toxicity among women with metastatic breast cancer","volume":"46","author":"Rosenzweig","year":"2019","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"10.1016\/j.urology.2022.08.053_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/JU.0000000000001423","article-title":"Patient-reported financial toxicity associated with contemporary treatment for localized prostate cancer","volume":"205","author":"Stone","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urology.2022.08.053_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cllc.2018.12.010","article-title":"Financial burden among patients with lung cancer in a publically funded health care system","volume":"20","author":"Ezeife","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.urology.2022.08.053_bib0022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.urology.2022.08.053_bib0023","first-page":"1","article-title":"Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in Japanese patients with cancer","volume":"2019","author":"Honda","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.urology.2022.08.053_bib0024","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00467-014-3012-3","article-title":"Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden","volume":"30","author":"Kusumi","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.urology.2022.08.053_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ijgc-2021-002475","article-title":"Evaluating meaningful levels of financial toxicity in gynecologic cancers","volume":"31","author":"Esselen","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.urology.2022.08.053_bib0026","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.juro.2015.10.082","article-title":"Medication nonadherence and effectiveness of preventive pharmacological therapy for kidney stones","volume":"195","author":"Dauw","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0027","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/ki.1996.489","article-title":"The financial effects of kidney stone prevention","volume":"50","author":"Parks","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.urology.2022.08.053_bib0028","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/JU.0000000000001846","article-title":"Disparities in kidney stone disease: a scoping review","volume":"206","author":"Crivelli","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.08.053_bib0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00240-019-01136-y","article-title":"Disparities in care among patients presenting to the emergency department for urinary stone disease","volume":"48","author":"Schoenfeld","year":"2020","journal-title":"Urolithiasis"},{"key":"10.1016\/j.urology.2022.08.053_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2019.05.009","article-title":"Influence of socioeconomic factors on stone burden at presentation to tertiary referral center: data from the registry for stones of the kidney and ureter","volume":"131","author":"Bayne","year":"2019","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522008755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522008755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:55:14Z","timestamp":1758768914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522008755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":30,"alternative-id":["S0090429522008755"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.08.053","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Financial Burden of Nephrolithiasis and Predictors of Disease-specific Financial Toxicity","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.08.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}